Peter Virsik
Geschäftsführer bei ESSA PHARMA INC.
Vermögen: 68 826 $ am 30.04.2024
Profil
Peter A.
Virsik is currently the Chief Operating Officer & Executive Vice President at ESSA Pharma, Inc. He previously worked as an Associate Director at Gilead Sciences, Inc. from 2000 to 2005 and as the Senior Vice President-Corporate Development at XenoPort, Inc. from 2005 to 2015.
Virsik received his undergraduate degree from the University of California, Berkeley, his graduate degree from the University of Michigan, and his MBA from Kellogg School of Management.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
ESSA PHARMA INC
0,03% | 06.05.2024 | 11 246 ( 0,03% ) | 68 826 $ | 30.04.2024 |
Aktive Positionen von Peter Virsik
Unternehmen | Position | Beginn |
---|---|---|
ESSA PHARMA INC. | Geschäftsführer | 01.08.2016 |
Ehemalige bekannte Positionen von Peter Virsik
Unternehmen | Position | Ende |
---|---|---|
XENOPORT, INC. | Corporate Officer/Principal | 01.01.2015 |
GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01.01.2005 |
Ausbildung von Peter Virsik
Kellogg School of Management | Masters Business Admin |
University of Michigan | Graduate Degree |
University of California, Berkeley | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
ESSA PHARMA INC. | Health Technology |
GILEAD SCIENCES, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
XenoPort, Inc.
XenoPort, Inc. Pharmaceuticals: MajorHealth Technology XenoPort, Inc. operated as a biopharmaceutical company. Its products included horizant and regnite. The company was founded by Ronald W. Barrett, William J. Dower and Mark A. Gallop on December 17, 1999 and was headquartered in Atlanta, GA. | Health Technology |